My take on this sorry saga. The Board have lost sight of their duty to maximise s/h wealth. They are focussed on having sufficient cash to fund the continuance of the drug to trial participants. They are enamoured by the drug’s efficacy in treating DMD. We are LT shareholders who have taken a risk in investing in the drug and want to be compensated accordingly. We are at a crossroad with the current Board’s agenda.
- Forums
- ASX - By Stock
- PER
- Ann: $13.0 million Institutional Placement
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

Ann: $13.0 million Institutional Placement, page-295
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $727 | 72.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 2840316 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 3323423 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2740316 | 0.010 |
6 | 5659202 | 0.009 |
4 | 1260267 | 0.008 |
3 | 1642854 | 0.007 |
2 | 3200000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 3323423 | 6 |
0.012 | 1139598 | 3 |
0.013 | 1000000 | 1 |
0.014 | 2072000 | 4 |
0.015 | 1500000 | 1 |
Last trade - 12.00pm 20/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |